ArticleAnnals of medicine and surgery (2012)2026

Fitusiran (Qfitlia) as a first-in-class RNA interference therapeutic: targeting antithrombin for prophylactic hemostasis in hemophilia.

Ehtisham Haider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.